FDA Inspection 1209821 — Lotus Laboratories Pvt. Ltd.
The FDA completed an inspection of Lotus Laboratories Pvt. Ltd. on May 26, 2023 in Bangalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 26, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bangalore (India)
Additional Details
Clinical BA/BE